• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>GlaxoSmithKline PLC ADR

GlaxoSmithKline PLC ADR

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  6. Research
  1. Isis Pharmaceuticals Earns $9M for Advancing ISIS-SMN Rx in Infants With Spinal Muscular Atrophy

    Isis Pharmaceuticals Earns $9M for Advancing ISIS-SMN Rx in Infants With Spinal Muscular Atrophy

  2. Research and Markets: Global Smoking Cessation Pipeline Review 2015 - 16 Companies & 23 Drug Profiles

    Research and Markets: Global Smoking Cessation Pipeline Review 2015 - 16 Companies & 23 Drug Profiles

  3. Novartis, GlaxoSmithKline Complete Deals

    Novartis, GlaxoSmithKline Complete Deals

  4. Novartis, GlaxoSmithKline Complete Series of Deals - Update

    Novartis, GlaxoSmithKline Complete Series of Deals - Update

  5. GSK Says Melanoma Drug Test Shows Significant Death Reduction

    GSK Says Melanoma Drug Test Shows Significant Death Reduction

  6. Isis Reports Financial Results and Highlights for 2014

    Isis Reports Financial Results and Highlights for 2014

  7. ISIS Pharmaceuticals Reports Positive Phase 1 Data Demonstrating ISIS-PKK Rx Produces Significant Reductions in Prekallikrein Levels

    ISIS Pharmaceuticals Reports Positive Phase 1 Data Demonstrating ISIS-PKK Rx Produces Significant Reductions in Prekallikrein Levels

  8. UPDATE: FTSE 100 advances as resource shares gain

    UPDATE: FTSE 100 advances as resource shares gain

  9. UPDATE: Broker does a 180 on Glaxo; shares surge

    UPDATE: Broker does a 180 on Glaxo; shares surge

  10. Novavax starts Ebola vaccine trials on humans

    Novavax starts Ebola vaccine trials on humans

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.